Roche
RO.SW
#40
Rank
NZ$562.21 B
Marketcap
NZ$706.64
Share price
0.86%
Change (1 day)
24.46%
Change (1 year)

Roche (RO.SW) - Cash on Hand

Cash on Hand as of December 2025 : NZ$33.08 Billion

According to Roche's latest financial reports the company has NZ$33.08 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Roche - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31NZ$33.75 B-0.71%
2024-12-31NZ$33.99 B71.98%
2023-12-31NZ$19.76 B18.7%
2022-12-31NZ$16.65 B-20.25%
2021-12-31NZ$20.87 B7.68%
2020-12-31NZ$19.39 B6.67%
2019-12-31NZ$18.17 B-8.58%
2018-12-31NZ$19.88 B14.61%
2017-12-31NZ$17.34 B34.42%
2016-12-31NZ$12.90 B-4.84%
2015-12-31NZ$13.56 B-10.24%
2014-12-31NZ$15.10 B-7.7%
2013-12-31NZ$16.37 B-12.16%
2012-12-31NZ$18.63 B20.89%
2011-12-31NZ$15.41 B1.96%
2010-12-31NZ$15.12 B-38.77%
2009-12-31NZ$24.69 B-28.05%
2008-12-31NZ$34.32 B22.96%
2007-12-31NZ$27.91 B-1.68%
2006-12-31NZ$28.38 B22.24%
2005-12-31NZ$23.22 B45.38%
2004-12-31NZ$15.97 B-20.22%
2003-12-31NZ$20.02 B-47.62%
2002-12-31NZ$38.22 B-48.85%
2001-12-31NZ$74.73 B26.88%
2000-12-31NZ$58.90 B29.07%
1999-12-31NZ$45.64 B18.48%
1998-12-31NZ$38.52 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$34.02 B 2.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$19.51 B-41.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$23.00 B-30.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$15.12 B-54.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.44 B-53.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$16.83 B-49.12%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$1.27 B-96.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$24.64 B-25.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$7.19 B-78.24%๐Ÿ‡ฌ๐Ÿ‡ง UK